Literature DB >> 33401540

Role of PUM RNA-Binding Proteins in Cancer.

Maciej J Smialek1, Erkut Ilaslan1, Marcin P Sajek1, Jadwiga Jaruzelska1.   

Abstract

Until recently, post-transcriptional gene regulation (PTGR), in contrast to transcriptional regulation, was not extensively explored in cancer, even though it seems to be highly important. PUM proteins are well described in the PTGR of several organisms and contain the PUF RNA-binding domain that recognizes the UGUANAUA motif, located mostly in the 3' untranslated region (3'UTR) of target mRNAs. Depending on the protein cofactors recruited by PUM proteins, target mRNAs are directed towards translation, repression, activation, degradation, or specific localization. Abnormal profiles of PUM expression have been shown in several types of cancer, in some of them being different for PUM1 and PUM2. This review summarizes the dysregulation of PUM1 and PUM2 expression in several cancer tissues. It also describes the regulatory mechanisms behind the activity of PUMs, including cooperation with microRNA and non-coding RNA machineries, as well as the alternative polyadenylation pathway. It also emphasizes the importance of future studies to gain a more complete picture of the role of PUM proteins in different types of cancer. Such studies may result in identification of novel targets for future cancer therapies.

Entities:  

Keywords:  3′ untranslated regions; 3′UTR; PTGR; PUM proteins; cancer; mRNA; post-transcriptional gene regulation

Year:  2021        PMID: 33401540      PMCID: PMC7796173          DOI: 10.3390/cancers13010129

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  69 in total

1.  Structure of Pumilio reveals similarity between RNA and peptide binding motifs.

Authors:  T A Edwards; S E Pyle; R P Wharton; A K Aggarwal
Journal:  Cell       Date:  2001-04-20       Impact factor: 41.582

2.  Kif18a is specifically required for mitotic progression during germ line development.

Authors:  Jason Stumpff; Laura G Reinholdt; Anne Czechanski; Haein Kim; Candice Byers; Ian Greenstein
Journal:  Dev Biol       Date:  2015-03-28       Impact factor: 3.582

3.  The Puf3 protein is a transcript-specific regulator of mRNA degradation in yeast.

Authors:  W Olivas; R Parker
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

4.  The Pumilio protein binds RNA through a conserved domain that defines a new class of RNA-binding proteins.

Authors:  P D Zamore; J R Williamson; R Lehmann
Journal:  RNA       Date:  1997-12       Impact factor: 4.942

5.  Mouse Pum1 and Pum2 genes, members of the Pumilio family of RNA-binding proteins, show differential expression in fetal and adult hematopoietic stem cells and progenitors.

Authors:  Danislav S Spassov; Roland Jurecic
Journal:  Blood Cells Mol Dis       Date:  2003 Jan-Feb       Impact factor: 3.039

6.  Human Ccr4-Not complexes contain variable deadenylase subunits.

Authors:  Nga-Chi Lau; Annemieke Kolkman; Frederik M A van Schaik; Klaas W Mulder; W W M Pim Pijnappel; Albert J R Heck; H Th Marc Timmers
Journal:  Biochem J       Date:  2009-08-27       Impact factor: 3.857

7.  PUMILIO hyperactivity drives premature aging of Norad-deficient mice.

Authors:  Mahmoud M Elguindy; Mehmet E Yalvac; Florian Kopp; He Zhang; Beibei Chen; Frank A Gillett; Sungyul Lee; Sushama Sivakumar; Hongtao Yu; Yang Xie; Prashant Mishra; Zarife Sahenk; Joshua T Mendell
Journal:  Elife       Date:  2019-02-08       Impact factor: 8.140

8.  Computational assessment of the cooperativity between RNA binding proteins and MicroRNAs in Transcript Decay.

Authors:  Peng Jiang; Mona Singh; Hilary A Coller
Journal:  PLoS Comput Biol       Date:  2013-05-30       Impact factor: 4.475

9.  The RNA binding domain of Pumilio antagonizes poly-adenosine binding protein and accelerates deadenylation.

Authors:  Chase A Weidmann; Nathan A Raynard; Nathan H Blewett; Jamie Van Etten; Aaron C Goldstrohm
Journal:  RNA       Date:  2014-06-18       Impact factor: 4.942

10.  LncRNA MACC1-AS1 sponges multiple miRNAs and RNA-binding protein PTBP1.

Authors:  Xiaona Zhang; Yanchun Zhou; Shaoying Chen; Wei Li; Weibing Chen; Wei Gu
Journal:  Oncogenesis       Date:  2019-12-10       Impact factor: 7.485

View more
  6 in total

1.  Distinct Roles of NANOS1 and NANOS3 in the Cell Cycle and NANOS3-PUM1-FOXM1 Axis to Control G2/M Phase in a Human Primordial Germ Cell Model.

Authors:  Erkut Ilaslan; Krystyna Kwiatkowska; Maciej Jerzy Smialek; Marcin Piotr Sajek; Zaneta Lemanska; Matisa Alla; Damian Mikolaj Janecki; Jadwiga Jaruzelska; Kamila Kusz-Zamelczyk
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

Review 2.  A mechanistic view of long noncoding RNAs in cancer.

Authors:  Lauren Winkler; Nadya Dimitrova
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-10-19       Impact factor: 9.349

3.  Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2.

Authors:  Lei Xu; Bin Zhang; Wenlan Li
Journal:  Mol Med Rep       Date:  2021-02-12       Impact factor: 2.952

Review 4.  AGO-RBP crosstalk on target mRNAs: Implications in miRNA-guided gene silencing and cancer.

Authors:  Pavan Kumar Kakumani
Journal:  Transl Oncol       Date:  2022-04-26       Impact factor: 4.803

5.  Emerging Roles of NANOS RNA-Binding Proteins in Cancer.

Authors:  Erkut Ilaslan; Marcin Piotr Sajek; Jadwiga Jaruzelska; Kamila Kusz-Zamelczyk
Journal:  Int J Mol Sci       Date:  2022-08-20       Impact factor: 6.208

6.  Prediction and analysis of functional RNA structures within the integrative genomics viewer.

Authors:  Warren B Rouse; Ryan J Andrews; Nicholas J Booher; Jibo Wang; Michael E Woodman; Ernst R Dow; Theodore C Jessop; Walter N Moss
Journal:  NAR Genom Bioinform       Date:  2022-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.